|
|
||||||||
1 Meakins-Christie Laboratories, McGill University, Montreal H3A 2T5; 2 St. Michael's Hospital, University of Toronto, Toronto M5B 5W8; and 3 Asthma/COPD Research Centre, Section of Respiratory Diseases, University of Manitoba, Winnipeg, Canada R3T 2N2
| |
ABSTRACT |
|---|
|
|
|---|
The
aim of this study was to determine whether the effects of hypoxia on
aortic contractility reflect a decrease in smooth muscle activation
[phosphorylation of the 20-kDa myosin regulatory light chain
(LC20)], the capacity for myofibrillar ATP
hydrolysis (mATPase activity), or both. Our results
indicate that, in endothelium-denuded aortic rings from rats exposed to
hypoxia for 48 h (inspired O2 concentration = 10%), contractions to phenylephrine
and potassium chloride (KCl) are impaired compared with rings from
normoxic rats. The proportion of phosphorylated to total
LC20 during aortic contraction induced by 10
5
M phenylephrine was reduced after hypoxia (51.4 ± 5.4% in
normoxic control rats vs. 32.5 ± 4.7% in hypoxic rats,
P < 0.01). Aortic mATPase activity was also decreased
(maximum ATPase rate = 29.6 ± 3.4 and 20.7 ± 3.7 nmol · min
1 · mg protein
1
in control and hypoxic rats, respectively, P < 0.05).
Neither proliferation nor dedifferentiation of aortic smooth muscle was evident in this model; immunostaining for smooth muscle expression of
the proliferating cell nuclear antigen was negative and smooth muscle-specific isoforms of myosin heavy chains, h-caldesmon, and
calponin were increased, not decreased, after hypoxic exposure. Decreased aortic reactivity after hypoxia is associated with both impairment of smooth muscle activation and diminished capacity of the
actomyosin complex, once activated, to hydrolyze ATP. These changes
cannot be attributed to smooth muscle dedifferentiation or to reduced
contractile protein expression.
systemic circulation; vascular smooth muscle; contractile protein expression; blood flow regulation; oxygen delivery.
| |
INTRODUCTION |
|---|
|
|
|---|
THE VASCULAR REFLEXES THAT redistribute blood flow toward vital organs and enhance the capacity for oxygen extraction during acute hypoxia (minutes) are mediated by the sympathetic nervous system (4, 5, 9, 21). If hypoxia is prolonged (12-48 h), however, the reactivity of systemic arterial and arteriolar smooth muscle is decreased (1, 2, 10, 30) and sympathetic responses are impaired (16). This will limit the ability to maintain adequate vital organ oxygen supply if substrate supply must be increased to meet an increase in metabolic demand in the event of superimposed hypotension or if hypoxia acutely becomes more severe. Despite its clinical and physiological relevance, the mechanisms that mediate the effect of hypoxia on smooth muscle contractility are unknown.
Vascular smooth muscle contraction depends on sliding of myosin thick
filaments over thin filaments composed of actin polymer and the
regulatory proteins calponin, caldesmon, and tropomyosin. Initiation of
contraction is regulated by phosphorylation of the 20-kDa myosin light
chain (LC20; Refs. 19, 20), which
permits actin activation of ATPase activity in the head of the myosin heavy chain (MHC) to provide the energy for cross-bridge cycling. We,
therefore, hypothesized that vascular hyporeactivity after hypoxia may
result from impairment of activation (decreased LC20 phosphorylation), diminished capacity of the actomyosin complex, once
activated, to hydrolyse ATP, or both. Accordingly, the current study
was carried out to determine the effect of hypoxic exposure on the
level of LC20 phosphorylation during
-agonist-induced contraction and on myofibrillar ATPase activity in systemic vascular smooth muscle. Hypoxia has previously been shown to induce
proliferation and/or modulation from a contractile to a proliferative
phenotype in smooth muscle and mesangial cells (7, 8, 27).
An additional goal, therefore, was to determine whether the biochemical
and functional changes that occur in the systemic vascular smooth muscle after hypoxia are associated with a shift to a more
proliferative state with a corresponding decrease in contractile
protein expression (12, 13, 14, 26, 28).
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Studies were carried out in male Sprague-Dawley rats (200-250 g). All protocols were in accordance with standards set by the Canadian Council on Animal Care and were approved by the institutional animal care committee. As described previously (2), rats were placed in a Plexiglas chamber (30 × 18 × 15 cm) into which the flow of air and nitrogen was controlled independently and from which gas outflow was through an underwater seal. Gas samples were drawn periodically from the chamber for analysis (model 995, AVL Instruments, Graz, Austria) to ensure that the appropriate ambient PO2 was maintained. Animals exposed to hypoxia breathed a mixture containing 10% oxygen, whereas control animals breathed air only under otherwise identical conditions.
Standard chemicals were purchased from Sigma Chemical (St. Louis, MO).
Electrophoresis reagents were from Bio-Rad (Mississauga, Ontario), and
enhanced chemiluminescence reagents and film were from Amersham
(Oakville, Ontario). Antibodies from Sigma Chemical included primary
mouse monoclonal antibody to smooth muscle-specific
-actin,
polyclonal antisera to tropomyosin, SM1/SM2 smooth muscle MHC, smooth
muscle LC20, and secondary goat anti-mouse-HRP adsorbed against rat serum proteins. Rabbit anti-calponin and rabbit
anti-h-caldesmon were kindly donated by Dr. M Walsh, University of
Calgary. Donkey anti-rabbit-HRP was from Amersham, and Ki67 antibody
specific for proliferating cell nuclear antigen was purchased from DAKO (Mississauga, Ontario).
Functional studies.
Thoracic aortas from normoxic rats and rats exposed to hypoxia were
excised immediately after decapitation, cleaned, and sectioned into
4-mm rings. The endothelium was removed by gentle abrasion of the
luminal surface, and rings were mounted in jacketed organ baths
containing 95% O2-5% CO2-aerated
Krebs-Henseleit solution (composition in mM: 120 NaCl, 25 NaHCO3, 11.1 glucose, 4.76 KCl, 1.18 MgSO4 · 7H2O, 1.18 KH2PO4, and 2.5 CaCl2) maintained
at 37°C. During the 60-min equilibration, the bathing medium was
changed periodically and the rings stabilized at a baseline tension of 2 g. The absence of a functional endothelium was tested by
ascertaining whether acetylcholine (10
6 M) was effective
at relaxing aortic rings precontracted by phenylephrine (10
6 M). Failure of acetylcholine to elicit relaxation
was taken as evidence of successful endothelial ablation
(2). Phenylephrine and acetylcholine were then washed out,
and the tension was allowed to return to resting values.
Concentration-response curves to phenylephrine (10
9 to
10
4 M) or potassium chloride (KCl; 0-80 mM) were
then constructed. At the end of each experiment, aortic rings were
dried overnight and weighed.
LC20 phosphorylation.
Thoracic aortic segments (4 mm) from normoxic rats and from rats
exposed to hypoxia were denuded of endothelium (see Functional studies) and cut into helical strips. Strips were mounted
in organ bath myographs that contained Krebs solution, bubbled with
95% O2-5% CO2, and maintained at 37° C. Baseline tension was adjusted to 1.5 g, the optimum tension for
maximal contractile responses under our experimental conditions, and
equilibrated for 1 h. From each animal, one strip remained under
control conditions in the tissue bath; a second strip was stimulated
for 1 min with 10
5 M phenylephrine. This time point was
chosen because, in initial time course studies, stimulation for 1 min
produced a level of phosphorylation that was stably maintained after 5 min of stimulation, confirming that steady-state levels are achieved
within 1 min (data not shown). At the end of the stimulation period,
the strips were immediately freeze-clamped in liquid nitrogen and fixed
for 2 min in a mixture of dry ice, liquid nitrogen, and 20 mM
dithiothreitol (DTT) in 10% TCA acetone, followed by repeated washes
with DTT-free 10% TCA. Tissues were lyophilized, then extracted for
3 h at room temperature by agitation in extraction buffer of the
following composition: 8 M urea, 200 mM Tris, 220 mM glycine, 10 mM
DTT, 600 mM KI, 0.1% bromophenol blue, 10 mM EGTA, and 1 mM EDTA.
Extracts were filtered with 0.45 µM filter units before
electrophoresis on freshly prepared gels of the following composition:
separating gel: 10/0.27% acrylamide/bisacrylamide, 0.375 M Tris, pH
8.8, 40% glycerol, 0.5% ammonium persulfate, 0.044%
N,N,N',N'-tetramethylethylenediamine (TEMED); stacking gel: 2.25/0.12% acrylamide/bisacrylamide, 0.12 M
Tris, pH 6.8, 8.5 M urea, 0.6% ammonium persulfate, 0.2% TEMED. Constant volumes were loaded on each lane. Gels were electrophoresed in
a Novex miniblot apparatus (Helixx, Mississauga, Ontario) at constant
current (6 mA/gel) by using a running buffer of 50 mM Tris, 100 mM
glycine. Proteins were transferred for 16 h at 27 V constant
voltage onto 0.22-µm pore nitrocellulose by using 0.1 M
3-(cyclohexylamino)-1-propane sulfonic acid (CAPS) buffer (pH 11.0). Immunoblotting was carried out by using
LC20-specific antibody (see below). Bands representing
phosphorylated and unphosphorylated LC20 were quantified by
densitometry, and phosphorylated LC20 was expressed as a
percent of the total LC20 for each lane. In instances in
which a third band, representing diphosphorylated LC20, was
detected (Fig. 1), the phosphorylated
fraction was taken as the sum of monophosphorylated and
diphosphorylated bands. A standard curve of chicken gizzard myosin
(Sigma Chemical), extracted simultaneously with the experimental
samples, was routinely loaded on the same gel to provide a positive
control and a measure of linearity of the optical density curve.
Tissues from control and hypoxic rats were always paired for
extraction, electrophoresis, and immunoblotting.
|
mATPase activity.
Thoracic aortas were excised from control rats and from rats exposed to
hypoxia for 48 h, frozen in liquid nitrogen, and stored at
70°C. Lysates were prepared by pulverizing the tissue in
mortar-pestle capsules prefrozen in liquid nitrogen by using a
high-speed dental amalgam mixer. The resulting tissue powder was then
resuspended in ice-cold ATPase assay buffer [20 mM imidazole (pH 6.9),
1 mM cysteine, 61.4 mM KCl, 1 mM MgCl2, 1 mM ouabain, 10 mM
NaN3, 10 g/ml leupeptin, 0.25 mM phenylmethylsulfonyl
fluoride, 1 mM DTT] at a ratio of 100 µl/mg original tissue weight.
An aliquot of the lysate was removed, and protein concentration was
determined by the Bradford assay. From this, the total amount of
protein in the sample was calculated to express ATPase activity in
moles of Pi released per minute per milligrams of protein.
Protein extraction and electrophoresis.
Levels of MHCs,
-actin, tropomyosin, caldesmon, and calponin were
measured in the thoracic aortas from normoxic rats and rats exposed to
hypoxia by Western analysis. Aortas from these animals were excised,
frozen in liquid nitrogen, then ground with lysis buffer (0.25 M
sucrose, 40 mM MOPS-NaOH, pH 7.4, 1 mM EDTA, 2 mM EGTA, 1 mM DTT, 1 mM
phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, 10 µg/ml
soybean trypsin inhibitor plus 0.5% Nonidet P-40) in a prefrozen
mortar and pestle. Lysates were centrifuged, and supernatants
were stored at
70°C for protein analysis. Electrophoresis was
carried out by using 4-12% gradient SDS-PAGE minigels (Helixx). In addition, 4% SDS-PAGE gels were used for separation of MHC isoforms. Protein concentration was determined by Bradford assay, and
appropriate volumes of extraction buffer to produce constant protein
loading in each lane were mixed with SDS-loading buffer to a final
concentration of 0.25 M Tris, 5% mercaptoethanol, 0.03% bromophenol
blue, 11.5% glycerol, pH 6.8. Samples were heated to 95°C for 5 min,
then loaded and electrophoresed with running buffer of the following
composition: 0.025 M Tris, 0.192 M glycine, 10% SDS. Separated
proteins were transferred to 0.22-µm-pore nitrocellulose in 0.025 M
Tris, 0.192 M glycine, 20% methanol transfer buffer at constant
voltage. Time, temperature, and voltage of the transfer depended on the
size of the protein and were optimized for each individual protein in
pilot experiments. Control and hypoxic samples were always paired on
one gel to control for interexperimental variation. Protein loading and
transfer efficiency were verified in all cases after transfer by using
full-lane densitometry of the Ponceau red-stained membranes.
Immunoblotting. Immunoblotting was the same for SDS-PAGE and urea/glycerol preparations, except that the latter were thoroughly air dried before blocking to fix the protein onto the membrane. Membranes were blocked for 2 h at room temperature with 5% dried milk in Tween 20 Tris-base sodium (TTBS). All antibodies were diluted in TTBS with 1% dried milk, with incubations for 1 h (secondary antibody) or 1.5 h (primary antibody) at room temperature. Concentrations varied among primary antibodies and were individually optimized in pilot experiments; secondary antibodies were diluted 1:1,000. Nonspecific binding of the secondary antibody was absent under these conditions. Blots were developed by using enhanced chemiluminescence and were routinely in the linear range of optical density, as determined in pilot studies or by internal standards. Signals were digitized by using a Hewlett-Packard scanner, analyzed with commercially available software (31), and expressed as optical density in arbitrary units.
Proliferating cell nuclear antigen immunohistochemistry. Thoracic aortas from normoxic rats and from rats exposed to hypoxia for 48 h were removed and fixed in 4% paraformaldehyde. After soaking in 30% sucrose solution and paraffin mounting, tissues were cut into 7-mm sections. Sections were immunostained with the proliferating cell nuclear antigen (PCNA)-specific antiserum, Ki67, by using an avidin-biotin-peroxidase method. Briefly, sections were dewaxed in toluene and dehydrated in ethanol, then immersed in 2% hydrogen peroxide to block endogenous peroxidase activity. Sections were permeabilized with 0.2% Triton X-100 and incubated with 10% normal goat serum to reduce nonspecific binding of the antiserum. The serum was drained, and sections were incubated with Ki67 overnight at 4°C. Sections were then washed three times with PBS and incubated with biotin-conjugated anti-mouse IgG for 60 min. After further washing with PBS, samples were incubated with avidin-biotin-peroxidase complex (Vectastain Elite kit, Vector Laboratories, Burlingame, CA) for 60 min at room temperature. Immunoreactive sites were visualized with diaminobenzine and hydrogen peroxide. Preparations were then counterstained with hematoxylin, dehydrated, cleared, and covered with glass coverslips. For negative controls, sections were incubated with antiserum that had been neutralized by preincubation with ligand.
Data analysis. Differences among multiple means were analyzed by two-way ANOVA. If ANOVA revealed significant differences, post hoc analysis of differences between individual means was carried out by using the Student-Newman-Keuls procedure. Unless otherwise stated, data are presented as means ± SE in n number of animals, with P < 0.05 representing statistical significance.
| |
RESULTS |
|---|
|
|
|---|
Functional studies.
Maximum tensions recorded during both phenylephrine- and KCl-induced
contractions were reduced in endothelium-denuded aortic rings from rats
exposed to hypoxia compared with the normoxic control group (Fig.
2, Table
1).
|
|
Phosphorylation of LC20.
Stimulation with 10
5 M phenylephrine caused an increase
in LC20 phosphorylation in aortic strips from both normoxic
rats and rats exposed to hypoxia for 48 h. Hypoxic exposure
significantly decreased phosphorylation of LC20 in response
to phenylephrine stimulation (Fig. 1). LC20 phosphorylation
in unstimulated strips from control and hypoxia-exposed rats did not
differ (4.5 ± 2.3 vs. 3.5 ± 1.9% for normoxic and
hypoxia-exposed groups, respectively, P = 0.45 for difference).
mATPase activity.
The rate of liberation of Pi in the in vitro assay was
diminished in aortas from rats exposed to hypoxia for 48 h
compared with the normoxic controls (Fig.
3, A and B).
LC20 phosphorylation in the in vitro assay after
direct activation of myosin light chain kinase by the addition of
Ca2+ did not differ between the two groups (Fig.
3C), indicating that the difference in ATPase activity
is not due to a difference in vitro activation of actomyosin ATPase in
the reaction mixture.
|
Contractile protein expression.
Exposure to hypoxia for 48 h had no effect on the expression of
smooth muscle-specific
-actin (Fig. 4,
A and B) or tropomyosin (Fig. 4, C and
D). In contrast, levels of calponin (Fig.
5, A and B) and
caldesmon (Fig. 5, C and D) were increased in
aortas from hypoxic rats compared with the normoxic group. Caldesmon expression was approximately doubled after hypoxia (P < 0.01), and calponin was increased by more than sevenfold
(P < 0.01). Hypoxia also increased expression of the
smooth muscle MHC (P < 0.05) (Fig.
6). Protein separation using 4% SDS-PAGE
gels, followed by electrotransfer and then either nonspecific staining
of the membrane (India ink) or SM-1/SM-2 immunoblotting, revealed no differences between hypoxic and normoxic samples in the molecular weight of MHC, suggesting that MHC isoform expression was not altered
by hypoxia (data not shown).
|
|
|
Ki67 immunohistochemistry.
Immunohistochemical staining of aortic tissue slices by using Ki67
monoclonal antibody, specific for PCNA, failed to detect this antigen
in aortic smooth muscle cells in either normoxic rats or in rats
exposed to hypoxia for 48 h. In aortas from hypoxic rats, however,
the endothelium did show positive staining with this antibody,
providing a positive control for the preparation (Fig.
7).
|
| |
DISCUSSION |
|---|
|
|
|---|
The results of this study demonstrate that, after exposure to
hypoxia for 48 h, the agonist-induced contractions of rat aorta are reduced due to impaired smooth muscle contractility. This decrease
in vasoreactivity is associated with a reduction in phosphorylation of
LC20 during stimulation with
-agonist and a decrease in
aortic myofibrillar ATPase activity. Although previous studies have
suggested that hypoxia elicits a shift to a proliferative phenotype in
vascular smooth muscle cells, we found no evidence of aortic smooth
muscle proliferation in this model.
Previous studies of the effects of chronic hypoxia (weeks) on in vivo systemic vasoreactivity have yielded conflicting results. Augmented (1), impaired (10, 17), and unchanged (15) responses to agonist infusions have been reported in various models. Depression of in vivo pressor responses after 4 wk of hypoxia appeared to be mediated by a direct effect on the blood vessels because it was associated with decreased in vitro reactivity of aortic segments (10). Similarly, exposure to prolonged hypoxia of a shorter duration (12-48 h) has been shown to impair reflex pressor responsiveness (16) and in vitro reactivity of arterial segments (2). The mechanisms that mediate the effects of hypoxia on vascular reactivity are as yet unclear and appear to differ among acute (minutes), prolonged (hours to days), and chronic (weeks) durations of exposure (2, 10, 16).
In the present study, we have evaluated the effects of exposure to hypoxia in vivo on the in vitro reactivity of aortic segments. The study does not include experiments designed to dissociate the direct effects of hypoxia from those of changes in flow or neurohumoral mediators. Nevertheless, these factors comprise part of the response to systemic hypoxia, and the hypoxic exposures presented in this study simulate a clinically and physiologically relevant condition. Our results indicate that prolonged hypoxia depresses both phenylephrine- and KCl-induced contraction in endothelium-denuded aortic rings. This finding is consistent with previous results (2) and confirms that, in contrast to the response to acute hypoxia that elicits systemic arterial relaxation through endothelial release of nitric oxide (3), prostaglandins (25, 32), or hyperpolarizing factor(s) (18, 23), the effect of prolonged hypoxia is due to a change in aortic smooth muscle function. The magnitude of the decrease in the response to phenylephrine in the present study is comparable to the reduction in contraction to KCl (37 and 30% reductions in maximum tensions, respectively). This and the lack of effect of hypoxia on the EC50 for phenylephrine argue against mediation of the effect by mechanisms selectively affecting adrenoreceptor-mediated responses. Because the response to maximum depolarization is reduced, this effect cannot be attributed to smooth muscle membrane hyperpolarization.
Our data reveal that LC20 phosphorylation during
stimulation with phenylephrine is reduced in aortic strips from rats
exposed to hypoxia, which indicates that the decrease in contractility is, at least in part, due to a failure of activation of contraction. Although this pertains to
-agonist-induced contraction in our present study, the impairment of contraction also affects the response
to depolarization and so is likely mediated by mechanisms downstream of
the cell membrane. Altered expression of myosin light chain kinase or
the capacity for its activation by Ca2+-calmodulin
(19, 20) and/or changes in the activity of the opposing
myosin light chain phosphatase (11) are mechanisms that
would affect activation pathways common to both stimuli. Further
studies are now needed to assess the mechanisms' roles in the reduced
reactivity of systemic vascular smooth muscle after hypoxia.
Because the ATPase activity of the myosin molecule provides the chemical energy for cross-bridge cycling and contraction, we examined this activity in aortas from normoxic rats and rats exposed to hypoxia. Aortic mATPase activity was decreased in the hypoxia-exposed group, suggesting that hypoxia leads to changes that limit cross-bridge cycling energetics and contribute to the impairment of vasoreactivity. mATPase activity may be affected by changes in the protein composition of either thin or thick myofilaments. We found that the thin filament proteins actin and tropomyosin were unchanged by hypoxia, whereas the smooth muscle-specific isoforms of calponin and caldesmon were increased. Smooth muscle caldesmon binds to actin, tropomyosin, and myosin, and its interaction with these proteins potently inhibits actin-activated myosin ATPase activity (24). Similarly, calponin binds with high affinity to actin and inhibits actin-activated ATPase activity of smooth muscle myosin (the movement of actin over myosin in vitro) and force development in permeabilized smooth muscle strips and single smooth muscle cells (34-36). Therefore, enhanced expression of these two regulatory proteins suggests a possible explanation for the reduction in mATPase activity, which merits further evaluation.
Hypoxia has been shown to induce proliferation and/or modulation from a
contractile to a proliferative phenotype in mesangial and smooth muscle
cells (7, 8, 27, 37). Reduced content of smooth
muscle-specific isoforms of thick- and thin-filament proteins and the
appearance of immature or nonmuscle isoforms are characteristic of this
phenotypic change (6, 13, 38). Furthermore, in pulmonary
arterial smooth muscle, a shift in MHC expression in favor of lower
molecular mass (196-198 kDa) nonmuscle isoforms has been reported
after chronic hypoxia (14 days) and correlated with the development of
impaired reactivity of these vessels to agonists (26).
Accordingly, we proposed that transition to the proliferative phenotype
with a corresponding reduction in smooth muscle-specific
contractile-protein expression could account for the functional and
biochemical changes that we observed in aortic smooth muscle after
prolonged hypoxia. In contrast to our hypothesis, however, we found
that levels of smooth muscle
-actin are unchanged, and smooth muscle
myosin, caldesmon, and calponin are increased in aortas from hypoxic
compared with normoxic animals. Finally, aortic smooth muscle cells did
not express the proliferative marker PCNA under the
conditions that produced contractile impairment. Importantly, the
PCNA-specific antibody did label endothelial cells, providing a
positive control for these preparations. Neither proliferation
nor reduction in smooth muscle-specific contractile protein expression
could, therefore, be substantiated.
In summary, our results indicate that hypoxia attenuates the contractile responses of aortic smooth muscle, decreases LC20 phosphorylation after a contractile stimulus, and decreases mATPase activity. Reflex sympathetic augmentation of systemic vascular tone is essential to maintaining arterial blood pressure and vital organ perfusion during hemorrhage and other hypotensive stresses. Adrenoceptor-mediated adjustment of systemic arterial and arteriolar tone is also important in the adaptations that redistribute blood flow toward vital organs and augment oxygen extraction during reductions in oxygen delivery (5, 9). Impairment of the contractile capacity of the systemic vascular smooth muscle will handicap these responses and compromise the ability to defend vital organ oxygen supply. Smooth muscle contraction relies on LC20 phosphorylation for activation and on mATPase for energy. This study demonstrates that these two crucial processes are impaired by prolonged hypoxia (48 h). These changes may, therefore, play a pathophysiological role in events that evolve over this time frame, such as the organ system dysfunction that occurs during reductions in oxygen delivery due to shock and cardiopulmonary diseases.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: M. E. Ward, Saint Michael's Hospital, Rm. 6042 Bond Wing, 30 Bond St., Toronto, Ontario, Canada M5B 5W8 (E-mail: wardm{at}smh.toronto.on.ca).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/japplphysiol.00818.2001
Received 2 August 2001; accepted in final form 25 February 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Aoki, VS,
and
Robinson SM.
Hindquarters vascular responses in chronically hypoxic rats.
Am J Physiol
217:
661-665,
1969
2.
Auer, G,
and
Ward ME.
Impaired reactivity of rat aorta to phenylephrine and KCl after prolonged hypoxia: role of the endothelium.
J Appl Physiol
85:
411-417,
1998
3.
Brown, IP,
Thompson CI,
and
Belloni FL.
Role of nitric oxide in hypoxic coronary vasodilation in isolated perfused guinea pig heart.
Am J Physiol Heart Circ Physiol
264:
H821-H829,
1993
4.
Cain, SM.
Oxyen delivery and uptake in dogs during anemic and hypoxic hypoxia.
J Appl Physiol
74:
228-234,
1977.
5.
Cain, SM,
and
Chapler CK.
O2 extraction by canine hindlimb during
-adrenergic blockade and hypoxic hypoxia.
J Appl Physiol
48:
630-635,
1980
6.
Chamley-Campbell, J,
Campbell GR,
and
Ross R.
Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens.
J Cell Biol
89:
379-383,
1981
7.
Cooper, AL,
and
Beasley D.
Hypoxia stimulates proliferation and interleukin-1 alpha production in human vascular smooth muscle cells.
Am J Physiol Heart Circ Physiol
277:
H1326-H1337,
1999
8.
Dempsey, EC,
Das M,
Frid MG,
Xu Y,
and
Stenmark KR.
Hypoxic growth of bovine pulmonary artery smooth muscle cells: dependence on synergy, heterogeneity, and injury-induced phenotypic change.
Chest
114:
29-30,
1998[ISI][Medline].
9.
Doherty, JU,
and
Liang SS.
Arterial hypoxia in awake dogs: role of the sympathetic nervous system in mediating the systemic hemodynamic and regional blood flow responses.
J Lab Clin Med
104:
665-667,
1984[ISI][Medline].
10.
Doyle, MP,
and
Walker BR.
Attenuation of systemic vasoreactivity in chronically hypoxic rats.
Am J Physiol Regulatory Integrative Comp Physiol
260:
R1114-R1122,
1991
11.
Feng, J,
Ito M,
Nishikawa M,
Okinaka T,
Isaka N,
Hartshorne DJ,
and
Nakano T.
Dephosphorylation of distinct sites on the 20 kDa myosin light chain by smooth muscle myosin phosphatase.
FEBS Lett
448:
101-104,
1999[ISI][Medline].
12.
Glukhova, MA,
Kabakov AE,
Frid MG,
Ornatsky OI,
and
Belkin AM.
Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression.
Proc Natl Acad Sci USA
85:
9542-9546,
1998.
13.
Halayko, AJ,
Salari H,
Ma X,
and
Stephens NL.
Markers of airway smooth muscle cell phenotype.
Am J Physiol Lung Cell Mol Physiol
270:
L1040-L1051,
1996
14.
Halayko, AJ,
and
Solway J.
Molecular mechanisms of phenotypic plasticity in smooth muscle cells.
J Appl Physiol
90:
358-368,
2001
15.
Harrison, GL,
McMurtry IF,
and
Moore LG.
Meclofenamate potentiates vasoreactivity to
-adrenergic stimulation in chronically hypoxic guinea pigs.
Am J Physiol Heart Circ Physiol
251:
H496-H501,
1986
16.
Heistad, DD,
Wheeler RC,
and
Aoki VS.
Reflex cardiovascular responses after 36 hr of hypoxia.
Am J Physiol
220:
1673-1676,
1971
17.
Jin, H,
Yang RH,
Chen YF,
Thornton RM,
Jackson RM,
and
Oparil S.
Hemodynamic effects of arginine vasopressin in rats adapted to chronic hypoxia.
J Appl Physiol
66:
151-160,
1989
18.
Kamekura, I,
Okumura K,
Matsui H,
Mokuno S,
Toki Y,
Nakashima Y,
and
Ito T.
Mechanisms of hypoxic coronary vasodilation in isolated perfused rat hearts.
J Cardiovasc Pharmacol
33:
836-842,
1999[ISI][Medline].
19.
Kamm, KE,
and
Stull JT.
Myosin phosphorylation, force, and maximal shortening velocity in neurally stimulated smooth muscle.
Am J Physiol Cell Physiol
249:
C238-C247,
1985
20.
Kamm, KE,
and
Stull JT.
Activation of smooth muscle contraction: relation between myosin phosphorylation and stiffness.
Science
232:
80-82,
1986
21.
Kuwahira, I,
Gonzalez NC,
Heisler N,
and
Piiper J.
Changes in regional blood flow distribution and oxygen supply during hypoxia in conscious rats.
J Appl Physiol
74:
211-214,
1993
22.
Lanzetta, PA,
Alvarez LJ,
Reinach PS,
and
Candia OA.
An improved assay for nanomole amounts of inorganic phosphate.
Anal Biochem
100:
95-97,
1979[ISI][Medline].
23.
Liu, Q,
and
Flavahan NA.
Hypoxic dilatation of porcine small coronary arteries: role of endothelium and K+ATP-channels.
Br J Pharmacol
120:
728-734,
1997[ISI][Medline].
24.
Marston, SB,
Fraser IDC,
and
Huber PAJ
Smooth muscle caldesmon controls the strong binding interaction between actin-tropomyosin and myosin.
J Biol Chem
269:
32104-32109,
1994
25.
Messina, EJ,
Sun D,
Koller A,
Wolin MS,
and
Kaley G.
Role of endothelium-derived prostaglandins in hypoxia-elicited arteriolar dilation in rat skeletal muscle.
Circ Res
71:
790-796,
1992
26.
Packer, CS,
Roepke JE,
Oberlies NH,
and
Roades RA.
Myosin isoform shifts and decreased reactivity in hypoxia-induced hypertensive pulmonary arterial muscle.
Am J Physiol Lung Cell Mol Physiol
274:
L775-L785,
1998
27.
Sahai, A,
Mei C,
Pattison TA,
and
Tannen RL.
Chronic hypoxia induces proliferation of cultured mesangial cells: role of calcium and protein kinase C.
Am J Physiol Renal Physiol
273:
F954-F960,
1997
28.
Stephens, NL,
Halayko A,
and
Swyngehedauw B.
Myosin heavy chain isoform distribution in normal and hypertrophied rat aortic smooth muscle.
Can J Physiol Pharmacol
69:
8-14,
1991[ISI][Medline].
29.
Toporsian, M,
Govindaraju K,
Nagi M,
Eidelman D,
Thibault G,
and
Ward ME.
Downregulation of endothelial nitric oxide synthase in rat aorta after prolonged hypoxia in vivo.
Circ Res
86:
671-675,
2000
30.
Toporsian, MT,
and
Ward ME.
Hyporeactivity of rat diaphragmatic arterioles following exposure to hypoxia in-vivo: role of the endothelium.
Am J Respir Crit Care Med
156:
1572-1578,
1997
31.
Vincent, SG,
Cunningham PR,
Stephens NL,
Halayko AJ,
and
Fischer JT.
Quantitative densitometry of proteins stained with coomassie blue using a Hewlett Packard scanjet scanner and Scanplot software.
Electrophoresis
81:
67-71,
1997.
32.
Ward, ME.
Dilation of rat diaphragmatic arterioles by flow and hypoxia: roles of nitric oxide and prostaglandins.
J Appl Physiol
86:
1644-1650,
1999
33.
Wilderman, MJ,
and
Armstead WM.
Role of endothelial nitric oxide synthase in hypoxia-induced pial artery dilation.
J Cereb Blood Flow Metab
18:
531-538,
1998[ISI][Medline].
34.
Winder, SJ,
Allen BG,
Fraser ED,
Kang HM,
Kargacin GJ,
and
Walsh MP.
Calponin phosphorylation in vitro and in intact muscle.
Biochem J
296:
827-836,
1993[ISI][Medline].
35.
Winder, SJ,
and
Walsh MP.
Smooth muscle calponin. Inhibition of actomyosin MgATPase and regulation by phosphorylation.
J Biol Chem
265:
10148-10155,
1990
36.
Winder, SJ,
and
Walsh MP.
Calponin: thin filament-linked regulation of smooth muscle contraction.
Cell Signal
5:
677-686,
1993[ISI][Medline].
37.
Wohrley, JD,
Frid MG,
Moiseeva EP,
Orton EC,
Bellknap JK,
and
Steinmark KR.
Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media.
J Clin Invest
96:
273-281,
1995[ISI][Medline].
38.
Wong, JZ,
Woodcock-Mitchell J,
Mitchell J,
Rippetoe P,
White S,
Absher M,
Baldor L,
Evans J,
McHugh KM,
and
Low RB.
Smooth muscle actin and myosin expression in cultured airway smooth muscle cells.
Am J Physiol Lung Cell Mol Physiol
274:
L786-L792,
1998
This article has been cited by other articles:
![]() |
J. B. Ray, S. Arab, Y. Deng, P. Liu, L. Penn, D. W. Courtman, and M. E. Ward Oxygen regulation of arterial smooth muscle cell proliferation and survival Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H839 - H852. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Z. He, A. Quan, Y. Xu, H. Teoh, G. Wang, J. E. Fish, B. M. Steer, S. Itohara, P. A. Marsden, S. T. Davidge, et al. Induction of matrix metalloproteinase-2 enhances systemic arterial contraction after hypoxia Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H684 - H693. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Govindaraju, H. Teoh, Q. Hamid, P. Cernacek, and M. E. Ward Interaction between endothelial heme oxygenase-2 and endothelin-1 in altered aortic reactivity after hypoxia in rats Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H962 - H970. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Thompson, K. Aguan, and H. Zhou Chronic Hypoxia Inhibits Contraction of Fetal Arteries by Increased Endothelium-Derived Nitric Oxide and Prostaglandin Synthesis Reproductive Sciences, December 1, 2004; 11(8): 511 - 520. [Abstract] [PDF] |
||||
![]() |
H. Teoh, M. Zacour, A. D. Wener, L. Gunaratnam, and M. E. Ward Increased myofibrillar protein phosphatase-1 activity impairs rat aortic smooth muscle activation after hypoxia Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1182 - H1189. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |